Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.340.360.360.340.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.34 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.34
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.34
-5.56
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,560.5 Cr -4.1% -9.9% 55.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,926.0 Cr -1.2% -2.3% 5.3% Stock Analytics
DIVIS LABORATORIES ₹175,062.0 Cr -1% -0.9% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,806.0 Cr -1.3% 1.4% 38.1% Stock Analytics
CIPLA ₹112,910.0 Cr -0.1% 4.8% -6.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,755.0 Cr -2.8% -0.3% 1.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.1%

-9.9%

55.6%

SENSEX

-2%

-3.8%

-8.6%


You may also like the below Video Courses